Flavahan WA, Drier Y, Johnstone SE, et al. Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs. Nature. 2019;575(7781):229-233. doi:10.1038/s41586-019-1668-3
Ma Y, De Jager PL. Designing an epigenomic study. Mult Scler. 2018;24(5):604-609. doi:10.1177/1352458517750770
Blecher-Gonen R, Barnett-Itzhaki Z, Jaitin D, Amann-Zalcenstein D, Lara-Astiaso D, Amit I. High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states. Nat Protoc. 2013;8(3):539-54. doi:10.1038/nprot.2013.023
Dhingra P, Martinez-Fundichely A, Berger A, et al. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. Genome Biol. 2017;18(1):141. doi:10.1186/s13059-017-1266-3
Akondy RS, Fitch M, Edupuganti S, et al. Origin and differentiation of human memory CD8 T cells after vaccination. Nature. 2017;552(7685):362-367. doi:10.1038/nature24633
Buenrostro JD, Corces R, Lareau CA, et al. Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation. Cell. 2018;173(6):1535-1548.e16. doi:10.1016/j.cell.2018.03.074
Sandoval GJ, Hahn WC. Going beyond genetics to discover cancer targets. Genome Biol. 2017;18(1):95. doi:10.1186/s13059-017-1238-7
Yamakawa H, Cheng J, Penney J, et al. The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons. Cell Rep. 2017;20(6):1319-1334. doi:10.1016/j.celrep.2017.07.044
You D, Nilsson E, Tenen DE, et al. Dnmt3a is an epigenetic mediator of adipose insulin resistance. Elife. 2017;6. doi:10.7554/eLife.30766
Klein HU, De Jager PL. How do we measure the epigenome(s)?. Mult Scler. 2018;24(4):446-448. doi:10.1177/1352458517750772